| | | | | | | | | | | | | | | | |
| |
 | Issue Date FY: 2022 ( Subtotal = $1,061,180 ) |
| 2022 | 2022 | SUNNYBROOK RESEARCH INSTITUTE | 2075 BAYVIEW AVE | TORONTO | ON | | | CAN | R01GM133961 | Burn induces hypermetabolism via browning of the white adipose tissue | 000 | 3 | NIH | 4/12/2022 | $293,396 |
| 2022 | 2022 | SUNNYBROOK RESEARCH INSTITUTE | 2075 BAYVIEW AVE | TORONTO | ON | | | CAN | R01AG057665 | CSVD and AD: the drivers of late life dementia | 000 | 5 | NIH | 4/4/2022 | $254,176 |
| 2022 | 2022 | SUNNYBROOK RESEARCH INSTITUTE | 2075 BAYVIEW AVE | TORONTO | ON | | | CAN | R01DC017291 | The development and validation of a novel tool for the assessment of bulbar dysfunction in ALS | 000 | 5 | NIH | 6/24/2022 | $481,005 |
| 2022 | 2022 | SUNNYBROOK RESEARCH INSTITUTE | 2075 BAYVIEW AVE | TORONTO | ON | | | CAN | R01GM133961 | Burn induces hypermetabolism via browning of the white adipose tissue | 001 | 3 | NIH | 4/18/2022 | $32,603 |
|
 | Issue Date FY: 2021 ( Subtotal = $1,980,671 ) |
| 2021 | 2021 | SUNNYBROOK RESEARCH INSTITUTE | 2075 BAYVIEW AVE | TORONTO | ON | | | CAN | R01AG052488 | Sleep, Circadian Rhythms, and Mechanisms of Cognitive Decline in the Human Brain | 000 | 5 | NIH | 3/17/2021 | $687,355 |
| 2021 | 2021 | SUNNYBROOK RESEARCH INSTITUTE | 2075 BAYVIEW AVE | TORONTO | ON | | | CAN | R01DC017291 | The development and validation of a novel tool for the assessment of bulbar dysfunction in ALS | 000 | 4 | NIH | 6/29/2021 | $481,005 |
| 2021 | 2021 | SUNNYBROOK RESEARCH INSTITUTE | 2075 BAYVIEW AVE | TORONTO | ON | | | CAN | R01AG057665 | CSVD and AD: the drivers of late life dementia | 000 | 4 | NIH | 3/30/2021 | $324,961 |
| 2021 | 2021 | SUNNYBROOK RESEARCH INSTITUTE | 2075 BAYVIEW AVE | TORONTO | ON | | | CAN | R01DC017291 | The development and validation of a novel tool for the assessment of bulbar dysfunction in ALS | 001 | 4 | NIH | 8/4/2021 | $186,859 |
| 2021 | 2021 | SUNNYBROOK RESEARCH INSTITUTE | 2075 BAYVIEW AVE | TORONTO | ON | | | CAN | R01GM133961 | Burn induces hypermetabolism via browning of the white adipose tissue | 000 | 2 | NIH | 4/1/2021 | $325,999 |
| 2021 | 2018 | SUNNYBROOK RESEARCH INSTITUTE | 2075 BAYVIEW AVE | TORONTO | ON | | | CAN | R21EB023996 | Ultrasound-mediated drug delivery for the treatment of leptomeningeal metastases | 000 | 2 | NIH | 2/6/2021 | -$25,503 |
| 2021 | 2018 | SUNNYBROOK RESEARCH INSTITUTE | 2075 BAYVIEW AVE | TORONTO | ON | | | CAN | R01GM087285 | Hepatic ER stress contributes to morbidity and mortality after burn injury. | 000 | 8 | NIH | 2/20/2021 | -$5 |
|
 | Issue Date FY: 2020 ( Subtotal = $2,843,173 ) |
| 2020 | 2020 | SUNNYBROOK RESEARCH INSTITUTE | 2075 BAYVIEW AVE | TORONTO | ON | M4N 3M5 | | CAN | R01AG057665 | CSVD and AD: the drivers of late life dementia | 000 | 3 | NIH | 3/20/2020 | $375,965 |
| 2020 | 2020 | SUNNYBROOK RESEARCH INSTITUTE | 2075 BAYVIEW AVE | TORONTO | ON | M4N 3M5 | | CAN | R01AG052488 | Sleep, Circadian Rhythms, and Mechanisms of Cognitive Decline in the Human Brain | 000 | 4 | NIH | 4/14/2020 | $693,555 |
| 2020 | 2020 | SUNNYBROOK RESEARCH INSTITUTE | 2075 BAYVIEW AVE | TORONTO | ON | M4N 3M5 | | CAN | R01DA042299 | Acute Pain Management and Long-term Opioid Use after Surgery | 000 | 4 | NIH | 6/23/2020 | $475,888 |
| 2020 | 2020 | SUNNYBROOK RESEARCH INSTITUTE | 2075 BAYVIEW AVE | TORONTO | ON | M4N 3M5 | | CAN | R01DC017291 | The development and validation of a novel tool for the assessment of bulbar dysfunction in ALS | 000 | 2 | NIH | 3/5/2020 | $35,310 |
| 2020 | 2020 | SUNNYBROOK RESEARCH INSTITUTE | 2075 BAYVIEW AVE | TORONTO | ON | M4N 3M5 | | CAN | R01DC017291 | The development and validation of a novel tool for the assessment of bulbar dysfunction in ALS | 001 | 3 | NIH | 6/29/2020 | $70,614 |
| 2020 | 2020 | SUNNYBROOK RESEARCH INSTITUTE | 2075 BAYVIEW AVE | TORONTO | ON | M4N 3M5 | | CAN | R01DC017291 | The development and validation of a novel tool for the assessment of bulbar dysfunction in ALS | 001 | 3 | NIH | 6/29/2020 | $481,005 |
| 2020 | 2020 | SUNNYBROOK RESEARCH INSTITUTE | 2075 BAYVIEW AVE | TORONTO | ON | M4N 3M5 | | CAN | R01GM133961 | Burn induces hypermetabolism via browning of the white adipose tissue | 000 | 1 | NIH | 4/10/2020 | $324,000 |
| 2020 | 2020 | SUNNYBROOK RESEARCH INSTITUTE | 2075 BAYVIEW AVE | TORONTO | ON | M4N 3M5 | | CAN | R01EB003268 | Ultrasound Therapy Delivery Through Intact Skull | 001 | 23 | NIH | 6/9/2020 | $386,836 |
| 2020 | 2019 | SUNNYBROOK RESEARCH INSTITUTE | 2075 BAYVIEW AVE | TORONTO | ON | M4N 3M5 | | CAN | R01EB003268 | Ultrasound Therapy Delivery Through Intact Skull | 000 | 22 | NIH | 5/8/2020 | $0 |
| 2020 | 2018 | SUNNYBROOK RESEARCH INSTITUTE | 2075 BAYVIEW AVE | TORONTO | ON | M4N 3M5 | | CAN | R01GM087285 | Hepatic ER stress contributes to morbidity and mortality after burn injury. | 000 | 8 | NIH | 1/28/2020 | $0 |
| 2020 | 2017 | SUNNYBROOK RESEARCH INSTITUTE | 2075 BAYVIEW AVE | TORONTO | ON | M4N 3M5 | | CAN | R01EB017288 | Novel Ultrasound-Activated Microbubble Enhancement of Cancer Therapy: Optimizatio | 000 | 4 | NIH | 1/2/2020 | $0 |
|
 | Issue Date FY: 2019 ( Subtotal = $2,312,343 ) |
| 2019 | 2019 | SUNNYBROOK RESEARCH INSTITUTE | 2075 BAYVIEW AVE | TORONTO | ON | M4N 3M5 | | CAN | R01EB003268 | Ultrasound Therapy Delivery Through Intact Skull | 001 | 22 | NIH | 9/5/2019 | $383,362 |
| 2019 | 2019 | SUNNYBROOK RESEARCH INSTITUTE | 2075 BAYVIEW AVE | TORONTO | ON | M4N 3M5 | | CAN | R01AG052488 | Sleep, Circadian Rhythms, and Mechanisms of Cognitive Decline in the Human Brain | 000 | 3 | NIH | 2/15/2019 | $593,611 |
| 2019 | 2019 | SUNNYBROOK RESEARCH INSTITUTE | 2075 BAYVIEW AVE | TORONTO | ON | M4N 3M5 | | CAN | R01DA042299 | Acute Pain Management and Long-term Opioid Use after Surgery | 000 | 3 | NIH | 6/19/2019 | $485,662 |
| 2019 | 2019 | SUNNYBROOK RESEARCH INSTITUTE | 2075 BAYVIEW AVE | TORONTO | ON | M4N 3M5 | | CAN | R01DC017291 | The development and validation of a novel tool for the assessment of bulbar dysfunction in ALS | 000 | 2 | NIH | 6/27/2019 | $473,743 |
| 2019 | 2019 | SUNNYBROOK RESEARCH INSTITUTE | 2075 BAYVIEW AVE | TORONTO | ON | M4N 3M5 | | CAN | R01AG057665 | CSVD and AD: the drivers of late life dementia | 000 | 2 | NIH | 3/5/2019 | $269,353 |
| 2019 | 2019 | SUNNYBROOK RESEARCH INSTITUTE | 2075 BAYVIEW AVE | TORONTO | ON | M4N 3M5 | | CAN | R01AG057665 | CSVD and AD: the drivers of late life dementia | 001 | 2 | NIH | 8/29/2019 | $106,612 |
| 2019 | 2018 | SUNNYBROOK RESEARCH INSTITUTE | 2075 BAYVIEW AVE | TORONTO | ON | M4N 3M5 | | CAN | R01EB003268 | Ultrasound Therapy Delivery Through Intact Skull | 000 | 21 | NIH | 9/4/2019 | $0 |
|
 | Issue Date FY: 2018 ( Subtotal = $2,725,571 ) (Continued on the next page) |
| 2018 | 2018 | SUNNYBROOK RESEARCH INSTITUTE | 2075 BAYVIEW AVE | TORONTO | ON | M4N 3M5 | | CAN | R01AG057665 | CSVD and AD: the drivers of late life dementia | 000 | 1 | NIH | 7/13/2018 | $250,059 |
| 2018 | 2018 | SUNNYBROOK RESEARCH INSTITUTE | 2075 BAYVIEW AVE | TORONTO | ON | M4N 3M5 | | CAN | R01DC017291 | The development and validation of a novel tool for the assessment of bulbar dysfunction in ALS | 000 | 1 | NIH | 7/20/2018 | $359,632 |
| 2018 | 2018 | SUNNYBROOK RESEARCH INSTITUTE | 2075 BAYVIEW AVE | TORONTO | ON | M4N 3M5 | | CAN | R01DA042299 | Acute Pain Management and Long-term Opioid Use after Surgery | 000 | 2 | NIH | 6/29/2018 | $491,141 |
| 2018 | 2018 | SUNNYBROOK RESEARCH INSTITUTE | 2075 BAYVIEW AVE | TORONTO | ON | M4N 3M5 | | CAN | R21EB023996 | Ultrasound-mediated drug delivery for the treatment of leptomeningeal metastases | 000 | 2 | NIH | 8/22/2018 | $137,365 |
| 2018 | 2018 | SUNNYBROOK RESEARCH INSTITUTE | 2075 BAYVIEW AVE | TORONTO | ON | M4N 3M5 | | CAN | R01AG052488 | Sleep, Circadian Rhythms, and Mechanisms of Cognitive Decline in the Human Brain | 003 | 2 | NIH | 5/2/2018 | -$570,528 |
| 2018 | 2018 | SUNNYBROOK RESEARCH INSTITUTE | 2075 BAYVIEW AVE | TORONTO | ON | M4N 3M5 | | CAN | R01AG052488 | Sleep, Circadian Rhythms, and Mechanisms of Cognitive Decline in the Human Brain | 003 | 2 | NIH | 5/2/2018 | $570,528 |
| 2018 | 2018 | SUNNYBROOK RESEARCH INSTITUTE | 2075 BAYVIEW AVE | TORONTO | ON | M4N 3M5 | | CAN | R01AG052488 | Sleep, Circadian Rhythms, and Mechanisms of Cognitive Decline in the Human Brain | 002 | 2 | NIH | 4/19/2018 | $57,052 |
| 2018 | 2018 | SUNNYBROOK RESEARCH INSTITUTE | 2075 BAYVIEW AVE | TORONTO | ON | M4N 3M5 | | CAN | R01AG052488 | Sleep, Circadian Rhythms, and Mechanisms of Cognitive Decline in the Human Brain | 002 | 2 | NIH | 4/19/2018 | $12,524 |
| 2018 | 2018 | SUNNYBROOK RESEARCH INSTITUTE | 2075 BAYVIEW AVE | TORONTO | ON | M4N 3M5 | | CAN | R01AG052488 | Sleep, Circadian Rhythms, and Mechanisms of Cognitive Decline in the Human Brain | 000 | 2 | NIH | 2/16/2018 | $513,476 |
| 2018 | 2018 | SUNNYBROOK RESEARCH INSTITUTE | 2075 BAYVIEW AVE | TORONTO | ON | M4N 3M5 | | CAN | R01AG052488 | Sleep, Circadian Rhythms, and Mechanisms of Cognitive Decline in the Human Brain | 000 | 2 | NIH | 2/16/2018 | $112,713 |
| 2018 | 2018 | SUNNYBROOK RESEARCH INSTITUTE | 2075 BAYVIEW AVE | TORONTO | ON | M4N 3M5 | | CAN | R01GM087285 | Hepatic ER stress contributes to morbidity and mortality after burn injury. | 000 | 8 | NIH | 9/12/2018 | $274,513 |
| 2018 | 2018 | SUNNYBROOK RESEARCH INSTITUTE | 2075 BAYVIEW AVE | TORONTO | ON | M4N 3M5 | | CAN | R01EB003268 | Ultrasound Therapy Delivery Through Intact Skull | 004 | 20 | NIH | 9/20/2018 | -$108,000 |
| 2018 | 2018 | SUNNYBROOK RESEARCH INSTITUTE | 2075 BAYVIEW AVE | TORONTO | ON | M4N 3M5 | | CAN | R01EB003268 | Ultrasound Therapy Delivery Through Intact Skull | 004 | 20 | NIH | 9/20/2018 | $108,000 |
| 2018 | 2018 | SUNNYBROOK RESEARCH INSTITUTE | 2075 BAYVIEW AVE | TORONTO | ON | M4N 3M5 | | CAN | R01EB003268 | Ultrasound Therapy Delivery Through Intact Skull | 002 | 21 | NIH | 8/27/2018 | $407,096 |
| 2018 | 2018 | SUNNYBROOK RESEARCH INSTITUTE | 2075 BAYVIEW AVE | TORONTO | ON | M4N 3M5 | | CAN | R01EB003268 | Ultrasound Therapy Delivery Through Intact Skull | 001 | 20 | NIH | 6/26/2018 | $108,000 |
| 2018 | 2018 | SUNNYBROOK RESEARCH INSTITUTE | 2075 BAYVIEW AVE | TORONTO | ON | M4N 3M5 | | CAN | R01EB003268 | Ultrasound Therapy Delivery Through Intact Skull | 001 | 20 | NIH | 6/26/2018 | -$108,000 |
|